US · IFF · CHEMICALS - SPECIALTY
International Flavors & Fragrances Inc. (IFF) intrinsic value and stock valuation
$79.62as of 2026-11-21 · Mkt cap 21.93B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
International Flavors & Fragrances Inc. DCF and intrinsic value
InvestorsCraft values IFF with the Chepakovich two-stage DCF model — currently rated strongly overvalued. How the model works · Run your own DCF prefilled from IFF’s statements →
International Flavors & Fragrances Inc. Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $10.9B | $11.5B | $11.5B | $12.4B | $11.7B |
| Operating income | $842M | $766M | -$-2.11B | -$-1.33B | $585M |
| Net income | -$-361M | $243M | -$-2.57B | -$-1.87B | $268M |
| EPSd | -$-1.41M | $949.2K | -$-10.06M | -$-7.33M | $1.1M |
| Operating cash flow | $850M | $1.07B | $1.44B | $397M | $1.44B |
| Capital expenditure | -$-594M | -$-468M | -$-503M | -$-506M | -$-397M |
| Free cash flow | $256M | $602M | $936M | -$-109M | $1.04B |
| Total assets | $25.5B | $28.7B | $31B | $35.5B | $39.7B |
| Total debt | $6.65B | $9.62B | $10.8B | $11.7B | $12.2B |
| Net debt | $6.06B | $9.15B | $10.1B | $11.3B | $11.5B |
| Total equity | $14.2B | $13.9B | $14.6B | $17.7B | $21.2B |
| Cash and short-term investments | $590M | $469M | $703M | $483M | $711M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $10.9B | $11.5B | $11.5B | $12.4B | $11.7B |
| Cost of revenue | $6.95B | $7.36B | $7.8B | $8.29B | $7.92B |
| Gross profit | $3.94B | $4.12B | $3.68B | $4.15B | $3.74B |
| Research and development expenses | $694M | $671M | $636M | $603M | $629M |
| Selling, general and administrative expenses | $1.83B | $2B | $1.79B | $1.77B | $1.75B |
| Other expenses | $568M | $692M | $3.37B | $3.11B | $772M |
| Operating expenses | $3.1B | $3.36B | $5.79B | $5.48B | $3.15B |
| Cost and expenses | $10B | $10.7B | $13.6B | $13.8B | $11.1B |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $229M | $305M | $380M | $336M | $289M |
| Depreciation and amortization | $962M | $1.02B | $1.14B | $1.18B | $1.16B |
| Ebitda | $779M | $1.6B | -$-996M | -$-110M | $1.8B |
| Operating income | $842M | $766M | -$-2.11B | -$-1.33B | $585M |
| Total other income/expenses, net | -$-1.25B | -$-488M | -$-408M | -$-299M | -$-231M |
| Income before tax | -$-412M | $278M | -$-2.52B | -$-1.63B | $354M |
| Income tax expense | -$-53M | $31M | $45M | $239M | $75M |
| Net income | -$-361M | $243M | -$-2.57B | -$-1.87B | $268M |
| Weighted average shares outstanding | $256M | $256M | $255M | $255M | $243M |
| Weighted average diluted shares outstanding | $256M | $256M | $255M | $255M | $243M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $590M | $469M | $703M | $483M | $711M |
| Net receivables | $2B | $1.97B | $2.09B | $2.16B | $2.22B |
| Inventory | $2.36B | $2.26B | $2.64B | $3.3B | $2.52B |
| Total current assets | $5.59B | $7.99B | $6.29B | $7.43B | $6.99B |
| Property, plant and equipment, net | $4.64B | $4.34B | $4.96B | $4.97B | $5.16B |
| Goodwill and intangible assets | $14.3B | $15.5B | $19B | $22.5B | $26.9B |
| Long-term investments | $15M | $10M | $11M | $10M | $86M |
| Total non-current assets | $19.9B | $20.7B | $24.7B | $28.1B | $32.7B |
| Total assets | $25.5B | $28.7B | $31B | $35.5B | $39.7B |
| Accounts payable | $1.29B | $1.28B | $1.38B | $1.42B | $1.53B |
| Short-term debt | $1.36B | $1.5B | $970M | $683M | $741M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $3.93B | $4.33B | $3.76B | $3.73B | $3.63B |
| Long-term debt | $5.29B | $8.1B | $9.83B | $11B | $11.4B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $7.42B | $10.4B | $12.6B | $14.1B | $14.8B |
| Capital lease obligations | $553M | $616M | $727M | $758M | $779M |
| Total liabilities | $11.4B | $14.8B | $16.3B | $17.8B | $18.4B |
| Common stock | $35M | $35M | $35M | $35M | $35M |
| Retained earnings | -$-3.42B | -$-2.61B | -$-2.44B | $955M | $3.64B |
| Accumulated other comprehensive income (loss) | -$-1.43B | -$-2.53B | -$-1.9B | -$-2.2B | -$-1.42B |
| Total equity | $14.2B | $13.9B | $14.6B | $17.7B | $21.2B |
| Total investments | $15M | $10M | $11M | $10M | $86M |
| Total debt | $6.65B | $9.62B | $10.8B | $11.7B | $12.2B |
| Net debt | $6.06B | $9.15B | $10.1B | $11.3B | $11.5B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | -$-359M | $247M | -$-2.56B | -$-1.84B | $279M |
| Depreciation and amortization | $962M | $1.02B | $1.14B | $1.18B | $1.16B |
| Stock-based compensation | $88M | $77M | $65M | $49M | $54M |
| Change in working capital | -$-421M | -$-115M | $485M | -$-1.07B | -$-153M |
| Accounts receivable | -$-68M | -$-217M | $51M | -$-117M | -$-169M |
| Inventory | -$-41M | -$-34M | $605M | -$-893M | -$-363M |
| Accounts payable | -$-57M | $40M | -$-39M | -$-57M | $419M |
| Net cash provided by operating activities | $850M | $1.07B | $1.44B | $397M | $1.44B |
| Investments in property, plant and equipment | -$-596M | -$-463M | -$-503M | -$-506M | -$-397M |
| Acquisitions, net | $2.76B | $875M | $1.05B | $1.07B | $361M |
| Net cash used for investing activities | $2.27B | $326M | $574M | $745M | -$-18M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-38M | -$-16M | $0.00 | $0.00 | $0.00 |
| Dividends paid | -$-409M | -$-514M | -$-826M | -$-810M | -$-667M |
| Net cash used for financing activities | -$-3.09B | -$-1.61B | -$-1.85B | -$-1.23B | -$-1.3B |
| Net change in cash | $119M | -$-240M | $216M | -$-222M | $58.2M |
| Cash at end of period | $590M | $469M | $709M | $493M | $715M |
| Operating cash flow | $850M | $1.07B | $1.44B | $397M | $1.44B |
| Capital expenditure | -$-594M | -$-468M | -$-503M | -$-506M | -$-397M |
| Free cash flow | $256M | $602M | $936M | -$-109M | $1.04B |
Line items
Line items
Line items
About International Flavors & Fragrances Inc.
International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1. Nourish: This segment focuses on natural and plant-derived specialty food ingredients, offering items like flavor compounds, savory solutions, and inclusions. It also provides natural food protection solutions, including antioxidants and anti-microbials, for use in beverages, confectionery, and dairy items. 2. Scent: The Scent division creates fragrance compounds, encompassing luxurious fine fragrances (perfumes and colognes) and everyday consumer fragrances. It further supplies essential fragrance ingredients, both synthetic and natural, which are blended to formulate new scents. Additionally, this segment delivers cosmetic active ingredients, such as functional compounds, botanicals, and advanced delivery systems, designed to enhance customers' cosmetic and personal care product lines. 3. Health & Biosciences: This segment is dedicated to the research, development, and production of enzymes, food cultures, probiotics, and other specialized biological ingredients. 4. Pharma Solutions: This division is responsible for manufacturing and distributing cellulosic and seaweed-derived pharmaceutical excipients. IFF's diverse customer base primarily consists of manufacturers in sectors including perfumery, cosmetics, hair and personal care, soaps and detergents, cleaning products, dairy, meat and processed foods, beverages, snacks and savory items, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional foods, and producers of pharmaceutical excipients and oral care products. Established in 1833, International Flavors & Fragrances Inc. is headquartered in New York, New York.
- CEO
- Jon Erik Fyrwald
- Employees
- 21.5K
- Beta
- 0.94
Included in
Explore
Frequently asked questions
What is the intrinsic value of International Flavors & Fragrances Inc. (IFF)?
International Flavors & Fragrances Inc. (IFF) is currently strongly overvalued based on the InvestorsCraft IC model — IC value is more than 50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is IFF undervalued?
IFF trades at a price of $79.62 (Nov 21, 2026): strongly overvalued — IC value is more than 50% below the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.